Skip to main content
The Indian Journal of Radiology & Imaging logoLink to The Indian Journal of Radiology & Imaging
. 2023 Oct 27;34(1):172–176. doi: 10.1055/s-0043-1774392

Very Rare Liver Tumor: PEComa Case Report with and a Review of Literature

Celal Yazıcı 1,, Elif Gündoğdu 1
PMCID: PMC10723948  PMID: 38106859

Abstract

Perivascular epithelioid cell tumors (PEComas) are very rare mesenchymal tumors. In addition to being rare in general, they are even rarer in the liver. There are various subtypes and there is only one case of liver PEComa reported in the clear cell type in the literature to date. We present the second clear cell type liver PEComa in this case by reviewing the literature data. The hypodense, smooth-edged, ovoid lesion was detected on computed tomography (CT) for performing abdominal pain in a 41-year-old female patient. Magnetic resonance imaging (MRI) was then performed for lesion characterization. The lesion was hypointense on T1-weighted imaging (T1WI), hyperintense on T2-weighted imaging (T2WI). In dynamic phases, it showed marked enhancement on the arterial phase and capsular enhancement with central washout on the portal and late venous phases. The posterior branch of the right portal vein extended into the mass. The lesion was excised and the pathological result was epithelioid clear cell subtype of PEComa. Although the imaging findings are generally nonspecific and certain diagnosis is made histopathologically, radiologists should consider PEComa in the differential diagnosis in the presence of intensely enhanced lesion on the right lobe in female patients. Also, the “large vessel sign” may help in the diagnosis.

Keywords: perivascular epithelioid cell tumors liver, computer tomography, magnetic resonance imaging

Introduction

Perivascular epithelioid cell tumors (PEComas) are very rare mesenchymal tumors. PEComas are composed of distinctive cells that show association with blood vessel walls and usually express melanocytic and smooth-muscle markers. 1 The PEComa tumor group includes tumors such as angiomyolipoma (AML), clear cell “sugar” tumor, lymphangioleiomyomatosis (LAM), and clear cell myomelanocytic tumor (CCMMT). They are far more common among women. 2

PEComas show a wide anatomical distribution, but most arise from the kidney, retroperitoneum, uterus, and pancreas in the abdomen. 1 3 Liver PEComas are extremely rare. They are usually discovered incidentally and benign in character. 4

In this study, we aimed to present an incidentally detected liver PEComa and its common radiological features by reviewing the literature data.

Case Report

A 41-year-old female patient had an incidental lesion in the liver on contrast-enhanced abdominal computed tomography (CT) performed for abdominal pain. The hypodense lesion was 35 × 30 mm in size, smooth-edged, and ovoid ( Fig. 1 ). Dynamic contrast-enhanced magnetic resonance imaging (MRI) was then performed for lesion characterization. The lesion was hypointense on T1-weighted images (T1WI) and hyperintense on T2-weighted images (T2WI), and there was no signal loss in fat-suppressed sequences ( Fig. 2 ) but there was restricted diffusion ( Fig. 3 ). In dynamic phases, the lesion showed marked enhancement in the arterial phase. Capsular enhancement with central washout was detected in the portal vein and late venous phases. In the hepatobiliary phase examination, the lesion was found to be hypointense ( Fig. 4 ). In the liver parenchyma, there was no finding in favor of chronic liver parenchymal disease and it was remarkable that the posterior branch of the right portal vein extended into the mass ( Fig. 5 ). The patient's hematological and biochemical parameters and tumor markers were within normal limits. With the preliminary diagnosis of hypervascular liver mass, the lesion was excised. Pathologically, HMB45, actin, vimentin, and melanin were positive. Findings were consistent with PEComa and epithelioid clear cell tumor subtype. So far, the patient has been followed for 66 months with no local recurrence or distant metastasis.

Fig. 1.

Fig. 1

Contrast-enhanced computed tomography (CT) image showing an ovoid, smoothly marginated, hypodense mass on the right lobe of the liver. Arrow is showing the lesion.

Fig. 2.

Fig. 2

( A ) Axial T2-weighted images showing the high-signal mass lesion in the right of liver. ( B ) Axial fat-suppressed T2-weighted images not showing the suppression of the signal. Arrows are showing the lesion.

Fig. 3.

Fig. 3

Diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI). ( A ) DWI and ( B ) apparent diffusion coefficient (ADC) map: a significant restricted diffusivity of the liver mass ( white arrow in A and black arrow in B ) is detected. Arrows are showing the lesion.

Fig. 4.

Fig. 4

Perivascular epithelioid cell tumor (PEComa) in segment VII demonstrating ( A ) bright enhancement at the arterial phase, ( B ) capsular enhancement at the portal phase, and ( C ) no enhancement at the hepatobiliary phase. Arrows are showing the lesion.

Fig. 5.

Fig. 5

A portal venous phase magnetic resonance (MR) scan demonstrating a vessel with direct contact to the right main portal vein (PV) and mass. Arrow is showing the vessel.

Discussion

PEComa can originate in almost any part of the body. Liver PEComa was classified by the World Health Organization (WHO) in 2002 as a mesenchymal tumor of the liver. 5 AML is the most common PEComa tumor in the liver and kidney. In our case, PEComa was a subtype of clear cell tumor, which is very rare in the liver PEComa tumor family. Clear cell PEComa is more common in middle-aged women and in the lung. 6 Extrapulmonary clear cell PEComas have been described in various organs such as the uterus and pancreas. 7 8 We found only one case of clear cell type PEComa in liver parenchyma in the literature. 6 In this case, the tumor was observed in the right lobe and in a middle-aged female patient similar to our case.

Up to now 30 liver non-AML PEComa cases have been reported in the literature ( Table 1 ). The mean age was calculated as 49.2 (range: 32–75) years. Six of the patients were males, and 24 were females. The average tumor size was about 5.9 cm (range: 0.8–17). It can be stated that liver PEComas are seen in a wide range of sizes. Nine of 30 masses in the literature were incidentally detected. The mass was detected in the right lobe in 19 cases, in the left lobe in 9 cases, and in both lobes in 2 cases. Histopathologically, only two cases were reported as malignant. According to these findings, PEComas are generally benign. They are detected as incidental. Clinical symptoms are nonspecific findings such as abdominal pain, swelling, and nausea. A mass was detected incidentally in our case. As in our case, PEComas occur more commonly in middle-aged female patients and in the right lobe.

Table 1. Review of the liver PEComa cases reported in the literature.

Study Age (y) Gender Hepatic lobe Size (cm) Symptom/finding Histologic Malign/benign
Fang et al 22 56 F Left 5.1 Abdominal pain PEComa Benign
Fang et al 22 63 F Left None Abdominal pain PEComa Benign
Svajdler et al 23 55 F Left 3.5 None PEComa Benign
Larbcharoensub et al 24 31 F Right 1.8 Abdominal pain CCMMT Benign
Zimmermann et al 17 53 M Right 8 Abdominal pain PEComa Benign
Paiva et al 25 51 F Left 0.8 Abdominal pain, weight loss PEComa Benign
Strzelczyk et al 6 50 F Right 17 Abdominal pain Clear cell sugar PEComa Benign
Priola et al 26 36 F Left 11 Abdominal pain PEComa Benign
Jafari et al 27 53 F Left 7.5 Hemorrhage PEComa Malign
Cheung et al 20 53 F Right 10 Abdominal pain PEComa Benign
Zhao et al 12 50 M Right 10 Abdominal pain PEComa Benign
Yu and Tang 28 41 F Right 2.2 Abdominal pain + fever PEComa Benign
Patra et al 29 50 F Right 24 Abdominal pain Pigmented PEComa Benign
Shen et al 9 55 M Right 1.6 Incidental PEComa Benign
Khaja et al 30 51 M Right None Incidental PEComa Benign
Liu et al 13 25 F Right 1.8 Incidental PEComa Benign
Ameurtesse et al 10 63 F Left 8 Abdominal pain PEComa Benign
Khan et al 15 61 M Right 7 Incidental PEComa Benign
Abhirup et al 11 72 F Both 10 Abdominal pain PEComa Malign
Arribas Jurado et al 31 45 F Right 4 Abdominal pain PEComa Benign
Schaeffer and Poulin 4 49 F Left 2.9 Abdominal pain PEComa Benign
Son et al 1 56 F Right 4.5 Incidental PEComa Benign
Kirnap et al 32 22 F Right 16 Incidental PEComa Benign
Voulgari et al 33 47 F Both 7 Abdominal pain PEComa Benign
Matrood et al 34 51 F Right 2 Incidental PEComa Benign
Kou et al 18 37 M Right 2.5 Abdominal pain PEComa Malign
Kou et al 18 70 F Left 5 Incidental PEComa Benign
Kou et al 18 30 F Right 5 Abdominal pain PEComa Benign
Harwal et al 19 27 F Right 10 Abdominal pain PEComa Benign
Perán Fernández et al 35 74 F Right 3.5 Incidental PEComa Benign

Abbreviations: CCMMT, clear cell myomelanocytic tumor; PEComa, perivascular epithelioid cell tumor.

PEComas have nonspecific CT and ultrasound findings. In MRI, they show high signal intensity on T2WI and low signal intensity on T1WI. 1 9 10 11 12 13 Heterogeneous enhancement in the arterial phase was noted in the literature. 9 14 15 16 17 Heterogeneous contrast enhancement may vary depending on the amount of fat and vascular and muscle cells it contains. The presence of washout in the portal and venous phases raises suspicion for hepatocellular carcinoma (HCC). 4 8 17 18 It can also restrict diffusion like HCC. 1 10 Hypervascular liver tumors such as focal nodular hyperplasia, hemangioma, and adenoma are included in the differential diagnosis. As the name implies, PEComas have abundant vascularity in or around the tumors. Therefore, they may show intense contrast enhancement and close vessel relationship, especially in contrast phases. 19 20 In the study of Gao et al, “large blood vessel” was observed in approximately 80% of liver PEComas. 21 In our case, the mass was observed to be associated with the right portal vein branch ( Fig. 5 ). Vascular feeding of PEComas may be helpful in the differentiation of HCC. In HCC, it may be associated with arteries and in PEComas with veins. 1

The definite diagnosis of PEComa is made histopathologically. Its histopathological features are diagnostic, and as its name signifies, it includes a group of cells with positive perivascularly located myocyte and melanocytic markers.

The appropriate treatment option is surgery. They usually have a benign course and rarely relapse-metastasize.

Conclusion

The incidence of PEComas is increasing due to the increase in imaging. Although the imaging findings are generally nonspecific, radiologists should consider PEComa in the differential diagnosis in the presence of intensely enhanced lesion in the right lobe in a female patient. Also, the “large vessel sign” may help in the diagnosis.

Funding Statement

Funding None.

Conflict of Interest None declared.

Author Contributions

C.Y. was responsible for the conceptualization, data curation, investigation, and writing the original draft. E.G. was responsible for formal analysis, investigation, review, supervision, and editing.

Consent for Publication

Informed consent was obtained from the patient prior to the study.

References

  • 1.Son H-J, Kang D W, Kim J H, Han H Y, Lee M K. Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures. Clin Mol Hepatol. 2017;23(01):80–86. doi: 10.3350/cmh.2016.0034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hornick J L, Fletcher C DM. PEComa: what do we know so far? Histopathology. 2006;48(01):75–82. doi: 10.1111/j.1365-2559.2005.02316.x. [DOI] [PubMed] [Google Scholar]
  • 3.Musella A, De Felice F, Kyriacou A K et al. Perivascular epithelioid cell neoplasm (PEComa) of the uterus: a systematic review. Int J Surg. 2015;19:1–5. doi: 10.1016/j.ijsu.2015.05.002. [DOI] [PubMed] [Google Scholar]
  • 4.Schaeffer D F, Poulin M P. Primary hepatic perivascular epithelioid tumor (PEComa) Ann Hepatol. 2016;15(03):436–437. doi: 10.5604/16652681.1198822. [DOI] [PubMed] [Google Scholar]
  • 5.Folpe A L, Kwiatkowski D J. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol. 2010;41(01):1–15. doi: 10.1016/j.humpath.2009.05.011. [DOI] [PubMed] [Google Scholar]
  • 6.Strzelczyk J M, Durczynski A, Szymanski D, Jablkowski M, Dworniak D, Sporny S. Primary perivascular epithelioid cell tumor (PEComa) of the liver: report of a case. Surg Today. 2009;39(10):916–921. doi: 10.1007/s00595-009-3945-5. [DOI] [PubMed] [Google Scholar]
  • 7.Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch. 2008;452(02):119–132. doi: 10.1007/s00428-007-0509-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Krawczyk M, Ziarkiewicz-Wróblewska B, Wróblewski T et al. PEComa: a rare liver tumor. J Clin Med. 2021;10(08):1756. doi: 10.3390/jcm10081756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shen H Q, Chen D F, Sun X H et al. MRI diagnosis of perivascular epithelioid cell tumor (PEComa) of the liver. Rom J Morphol Embryol. 2013;54(03):643–647. [PubMed] [Google Scholar]
  • 10.Ameurtesse H, Chbani L, Bennani A et al. Primary perivascular epithelioid cell tumor of the liver: new case report and literature review. Diagn Pathol. 2014;9:149. doi: 10.1186/1746-1596-9-149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Abhirup B, Kaushal K, Sanket M, Ganesh N. Malignant hepatic perivascular epithelioid cell tumor (PEComa): case report and a brief review. J Egypt Natl Canc Inst. 2015;27(04):239–242. doi: 10.1016/j.jnci.2015.05.004. [DOI] [PubMed] [Google Scholar]
  • 12.Zhao L J, Yang Y J, Wu H, Huang S M, Liu K. Perivascular epithelioid cell tumor of the liver: a case report and literature review. Eur Rev Med Pharmacol Sci. 2013;17(12):1665–1668. [PubMed] [Google Scholar]
  • 13.Liu D, Shi D, Xu Y, Cao L. Management of perivascular epithelioid cell tumor of the liver: a case report and review of the literature. Oncol Lett. 2014;7(01):148–152. doi: 10.3892/ol.2013.1689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zhuang Y, Zeng Y, Ying L, Song C. Epithelioid angiomyolipoma of the liver: a case report. Asian J Surg. 2023;46(03):1376–1377. doi: 10.1016/j.asjsur.2022.08.124. [DOI] [PubMed] [Google Scholar]
  • 15.Khan H M, Katz S C, Libbey N P, Somasundar P S. Hepatic PEComa: a potential pitfall in the evaluation of hepatic neoplasms. BMJ Case Rep. 2014;2014:bcr2014204122. doi: 10.1136/bcr-2014-204122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wang S, Xia H, Liu X, Liu Y, Lou C. Hepatic epithelioid angiomyolipoma mimicking hepatocellular carcinoma on MR and 18 F-FDG PET/CT imaging: a case report and literature review . Hell J Nucl Med. 2022;25(02):205–209. doi: 10.1967/s002449912480. [DOI] [PubMed] [Google Scholar]
  • 17.Zimmermann A, von der Brelie C, Berger B, Kappeler A, Candinas D. Primary perivascular epithelioid cell tumor of the liver not related to hepatic ligaments: hepatic PEComa as an emerging entity. Histol Histopathol. 2008;23(10):1185–1193. doi: 10.14670/HH-23.1185. [DOI] [PubMed] [Google Scholar]
  • 18.Kou Y Q, Yang Y P, Ye W X, Yuan W N, Du S S, Nie B. Perivascular epithelioid cell tumors of the liver misdiagnosed as hepatocellular carcinoma: three case reports. World J Clin Cases. 2023;11(02):426–433. doi: 10.12998/wjcc.v11.i2.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Harwal R, Joseph Rosemary L J, Raju P, Chidambaranathan S, Bharathi Vidya Jayanthi J, Obla Lakshmanamoorthy N B. Hepatic perivascular epithelioid cell tumor mimicking hepatocellular carcinoma. ACG Case Rep J. 2023;10(01):e00962. doi: 10.14309/crj.0000000000000962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cheung T T, Trendell-Smith N, Poon R T. Primary perivascular epithelioid cell tumour (PEComa) of the liver. BMJ Case Rep. 2013;2013:bcr2013008706. doi: 10.1136/bcr-2013-008706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Gao X, Tang H, Wang J et al. Specific imaging features indicate the clinical features of patients with hepatic perivascular epithelioid cell tumor by comparative analysis of CT and ultrasound imaging. Front Oncol. 2022;12:908189. doi: 10.3389/fonc.2022.908189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fang S H, Zhou L N, Jin M, Hu J B. Perivascular epithelioid cell tumor of the liver: a report of two cases and review of the literature. World J Gastroenterol. 2007;13(41):5537–5539. doi: 10.3748/wjg.v13.i41.5537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Svajdler M, Bohus P, Goc V, Tkácová V. Perivascular epithelioid cell tumor (PEComa) of the liver: a case report and review of the literature. Cesk Patol. 2007;43(01):18–22. [PubMed] [Google Scholar]
  • 24.Larbcharoensub N, Karnsombut P, Jatchavala J, Wasutit Y, Nitiyanant P. Primary hepatic clear cell myomelanocytic tumor. Case report and review of the literature. Acta Pathol Microbiol Scand Suppl. 2007;115(12):1454–1459. doi: 10.1111/j.1600-0463.2007.00733.x. [DOI] [PubMed] [Google Scholar]
  • 25.Paiva C E, Moraes Neto F A, Agaimy A, Custodio Domingues M A, Rogatto S R. Perivascular epithelioid cell tumor of the liver coexisting with a gastrointestinal stromal tumor. World J Gastroenterol. 2008;14(05):800–802. doi: 10.3748/wjg.14.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Priola A M, Priola S M, Cataldi A, Marci V, Fava C. Acute abdomen as an unusual presentation of hepatic PEComa. A case report. Tumori. 2009;95(01):123–128. doi: 10.1177/030089160909500124. [DOI] [PubMed] [Google Scholar]
  • 27.Jafari A, Fischer H P, von Websky M, Hong G S, Kalff J C, Manekeller S. Primary perivascular epitheloid cell tumour (PEComa) of the liver: case report and review of the literature. Z Gastroenterol. 2013;51(09):1096–1100. doi: 10.1055/s-0033-1350123. [DOI] [PubMed] [Google Scholar]
  • 28.Yu D, Tang S. Hepatic perivascular epithelioid cell tumor: a case report and review of the literature. Intern Med. 2013;52(12):1333–1336. doi: 10.2169/internalmedicine.52.0144. [DOI] [PubMed] [Google Scholar]
  • 29.Patra S, Vij M, Kota V, Kancherla R, Rela M. Pigmented perivascular epithelioid cell tumor of the liver: report of a rare case with brief review of literature. J Cancer Res Ther. 2013;9(02):305–307. doi: 10.4103/0973-1482.113401. [DOI] [PubMed] [Google Scholar]
  • 30.Khaja F, Carilli A, Baidas S, Sriharan A, Norford S. PEComa: a perivascular epithelioid cell tumor in the liver: a case report and review of the literature. Case Rep Med. 2013;2013:904126. doi: 10.1155/2013/904126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Arribas Jurado M, Revollo I, Rubio Fernández A, Galeano Díaz F, Blanco Fernández G. Primary liver PEComa. Cir Esp. 2015;93(09):600–601. doi: 10.1016/j.ciresp.2014.07.011. [DOI] [PubMed] [Google Scholar]
  • 32.Kirnap M, Ozgun G, Moray G, Haberal M. Perivascular epithelioid cell tumor outgrowth from the liver. Int J Surg Case Rep. 2018;53:295–298. doi: 10.1016/j.ijscr.2018.10.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Voulgari P V, Tatsi V, Milionis H J, Goussia A, Xydis V, Glantzounis G K. Liver perivascular epithelioid cell tumor in a patient with systemic lupus erythematosus. Int J Surg Case Rep. 2018;53:193–195. doi: 10.1016/j.ijscr.2018.10.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Matrood S, Görg C, Safai Zadeh E, Alhyari A. Hepatic perivascular epithelioid cell tumor (PEComa): contrast-enhanced ultrasound (CEUS) characteristics: a case report and literature review. Clin J Gastroenterol. 2023;16(03):444–449. doi: 10.1007/s12328-023-01779-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Perán Fernández C, de Paco Navaro Á, Castañer Ramón-Llin J, Bertelli Puche J, Sánchez Espinosa A. Perivascular epithelioid cell tumor (PEComa) of the liver. An extremely rare diagnosis. Rev Esp Enferm Dig. 2023;115(06):348–349. doi: 10.17235/reed.2023.9558/2023. [DOI] [PubMed] [Google Scholar]

Articles from The Indian Journal of Radiology & Imaging are provided here courtesy of Thieme Medical Publishers

RESOURCES